Newsletter | November 5, 2026

11.05.26 -- Reduce Risk From Drug Formulation Through Commercial Launch

 

Why Controlled Release Is Essential For Patient-Centric Drug Development

 

Controlled release in small molecule oral solid dosage reframes adherence as a formulation challenge, with implications for pediatric, geriatric, and chronic-illness patients and for the stability and scalability demands of commercial supply.

 
 

From FDA Approval To Product Launch

How do you maintain supply during a major product transfer? Explore strategies used to navigate technical, regulatory, and logistics challenges.

 

Considerations For A Successful Product Launch

Launch readiness depends on packaging design, validation strategy, and supply chain planning. Help reduce risk, maintain compliance, and support a smooth commercial launch.

 

Solubility And Improved Patient Outcomes

Poor solubility poses major development challenges. Innovative formulation technologies and careful excipient selection can improve bioavailability and product performance.

 

SOLUTIONS

Solid Oral Dose Formulation And Manufacturing Services

Moving a solid oral dose product from early formulation to commercial scale involves more than scale-up. Containment of highly potent compounds, analytical continuity, and the handoff between non-GMP and GMP environments shape how smoothly a program advances.

 

Tailor-Made Product Development, Manufacture & Commercial Solutions

Discover how integrated expertise, flexible capacity, advanced technologies, and global reach can support pharmaceutical products throughout each stage of their lifecycle.

 

RESOURCES